172 related articles for article (PubMed ID: 38459588)
1. PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1.
Huang F; Guo J; Zhao N; Hou M; Gai X; Yang S; Cai P; Wang Y; Ma Q; Zhao Q; Li L; Yang H; Jing Y; Jin D; Hu Z; Zha X; Wang H; Mao Y; Liu F; Zhang H
J Transl Med; 2024 Mar; 22(1):254. PubMed ID: 38459588
[TBL] [Abstract][Full Text] [Related]
2. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
Kladney RD; Cui X; Bulla GA; Brunt EM; Fimmel CJ
Hepatology; 2002 Jun; 35(6):1431-40. PubMed ID: 12029628
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice.
Liu Y; Qi X; Zeng Z; Wang L; Wang J; Zhang T; Xu Q; Shen C; Zhou G; Yang S; Chen X; Lu F
Sci Rep; 2017 Jun; 7(1):2796. PubMed ID: 28584302
[TBL] [Abstract][Full Text] [Related]
4. HBV-Induced Increased N6 Methyladenosine Modification of PTEN RNA Affects Innate Immunity and Contributes to HCC.
Kim GW; Imam H; Khan M; Mir SA; Kim SJ; Yoon SK; Hur W; Siddiqui A
Hepatology; 2021 Feb; 73(2):533-547. PubMed ID: 32394474
[TBL] [Abstract][Full Text] [Related]
5. GP73 facilitates hepatitis B virus replication by repressing the NF-κB signaling pathway.
Liu L; Zhu J; Yang J; Li X; Yuan J; Wu J; Liu Z
J Med Virol; 2020 Dec; 92(12):3327-3335. PubMed ID: 32077512
[TBL] [Abstract][Full Text] [Related]
6. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice.
Teng YC; Neo JC; Wu JC; Chen YF; Kao CH; Tsai TF
J Pathol; 2017 Mar; 241(4):463-474. PubMed ID: 27868197
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous phenotypes of Pten-null hepatocellular carcinoma in hepatitis B virus transgenic mice parallels liver lobule zonal gene expression patterns.
Oropeza CE; Ondracek CR; Tarnow G; Maienschein-Cline M; Green SJ; McLachlan A
Virology; 2022 Jan; 566():16-25. PubMed ID: 34844082
[TBL] [Abstract][Full Text] [Related]
8. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma.
Gao G; Dong F; Xu X; Hu A; Hu Y
Int J Clin Exp Pathol; 2015; 8(9):11379-85. PubMed ID: 26617863
[TBL] [Abstract][Full Text] [Related]
10. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection.
Cao Z; Li Z; Wang Y; Liu Y; Mo R; Ren P; Chen L; Lu J; Li H; Zhuang Y; Liu Y; Wang X; Zhao G; Tang W; Xiang X; Wang H; Cai W; Liu L; Zhu C; Bao S; Xie Q
J Viral Hepat; 2017 Nov; 24 Suppl 1():57-65. PubMed ID: 29082644
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus promotes hepatocellular carcinoma development by activating GP73 to repress the innate immune response.
Liu L; Huang Y; Fu Y; Rao J; Zeng F; Ji M; Xu X; Zhu J; Du W; Liu Z
Infect Agent Cancer; 2022 Oct; 17(1):52. PubMed ID: 36195933
[TBL] [Abstract][Full Text] [Related]
12. Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease.
Xu Z; Liu L; Pan X; Wei K; Wei M; Liu L; Yang H; Liu Q
Medicine (Baltimore); 2015 Mar; 94(12):e659. PubMed ID: 25816035
[TBL] [Abstract][Full Text] [Related]
13. Serum GP73, a marker for evaluating progression in patients with chronic HBV infections.
Wei H; Li B; Zhang R; Hao X; Huang Y; Qiao Y; Hou J; Li X; Li X
PLoS One; 2013; 8(2):e53862. PubMed ID: 23418424
[TBL] [Abstract][Full Text] [Related]
14. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
15. Distinct phenotypic spectra of hepatocellular carcinoma in liver-specific tumor suppressor-deficient hepatitis B virus transgenic mice.
Tarnow G; Matrenec R; Oropeza CE; Maienschein-Cline M; McLachlan A
Virology; 2022 Sep; 574():84-95. PubMed ID: 35961146
[TBL] [Abstract][Full Text] [Related]
16. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
17. HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation.
Niu LJ; Huang T; Wang L; Sun XF; Zhang YM
Ann Hepatol; 2022; 27(3):100688. PubMed ID: 35196550
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus x protein accelerated the proliferation of hepatocellular carcinoma cell through lncRNA SNHG20/PTEN pathway.
Tu W; Yang Y; Song Y; Zhu W
J Biochem; 2019 May; 165(5):423-431. PubMed ID: 30690477
[TBL] [Abstract][Full Text] [Related]
19. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
Gatselis NK; Tornai T; Shums Z; Zachou K; Saitis A; Gabeta S; Albesa R; Norman GL; Papp M; Dalekos GN
World J Gastroenterol; 2020 Sep; 26(34):5130-5145. PubMed ID: 32982114
[TBL] [Abstract][Full Text] [Related]
20. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population.
Hu JS; Wu DW; Liang S; Miao XY
Med Oncol; 2010 Jun; 27(2):339-45. PubMed ID: 19399652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]